Wedge Capital Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-603,750
Closed -$37.3M 629
2015
Q4
$37.3M Buy
603,750
+37,025
+7% +$2.34M 0.39% 91
2015
Q3
$35.8M Buy
+566,725
New +$40.4M 0.38% 86
2014
Q4
Sell
-643,775
Closed -$38.7M 611
2014
Q3
$38.7M Sell
643,775
-60,865
-9% -$3.98M 0.41% 81
2014
Q2
$48.8M Sell
704,640
-13,775
-2% -$893K 0.5% 55
2014
Q1
$47M Sell
718,415
-50,700
-7% -$3.3M 0.49% 68
2013
Q4
$47.6M Buy
769,115
+59,075
+8% +$3.42M 0.5% 58
2013
Q3
$38.1M Sell
710,040
-118,875
-14% -$6.12M 0.44% 81
2013
Q2
$37.8M Buy
+828,915
New +$35.9M 0.45% 73

Other funds holding STJ

Wedge Capital Management's STJ Position: Q1 2016 in Review

Wedge Capital Management sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 603,750 shares — an estimated $37.3M sold.

Wedge Capital Management first reported a position in STJ in Q2 2013 and held it in 8 quarters. The position peaked at $48.8M in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • Wedge Capital Management reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • Wedge Capital Management sold 603,750 St Jude Medical shares in Q1 2016, an estimated $37.3M.
  • Wedge Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 8 quarters.
  • Wedge Capital Management's St Jude Medical position peaked at $48.8M in Q2 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Wedge Capital Management's 13F filing for Q1 2016, filed 2 May 2016.